Accéder au contenu
Merck

Knockout of the peroxiredoxin 5 homologue PFAOP does not affect the artemisinin susceptibility of Plasmodium falciparum.

Scientific reports (2017-07-02)
Carine F Djuika, Verena Staudacher, Cecilia P Sanchez, Michael Lanzer, Marcel Deponte
RÉSUMÉ

Artemisinins are the current mainstay of malaria chemotherapy. Their exact mode of action is an ongoing matter of debate, and several factors have recently been reported to affect an early stage of artemisinin resistance of the most important human malaria parasite Plasmodium falciparum. Here, we identified a locus on chromosome 7 that affects the artemisinin susceptibility of P. falciparum in a quantitative trait locus analysis of a genetic cross between strains 7G8 and GB4. This locus includes the peroxiredoxin gene PFAOP. However, steady-state kinetic data with recombinant PfAOP do not support a direct interaction between this peroxidase and the endoperoxide artemisinin. Furthermore, neither the overexpression nor the deletion of the encoding gene affected the IC

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Dimethyl 3,3′-dithiopropionimidate dihydrochloride, powder